Table 4.
Patients with clinical improvement, failure or indeterminate response by infection site and pathogen (based on intent to treat)a
| Infection site/organism | Improved, n | Failed, n | Indeterminate, n |
|---|---|---|---|
| All sites, total | 25 | 16 | 11 |
| M. abscessus complex | 18 | 12 | 8 |
| M. chelonae | 5 | 3 | 1 |
| M. abscessus complex/ M. chelonae | 2 | 1 | 2 |
| Lung, total | 16 | 11 | 9 |
| M. abscessus complex | 13 | 9 | 8 |
| M. chelonae | 1 | 1 | 0 |
| M. abscessus complex/ M. chelonae | 2 | 1 | 1 |
| Extrapulmonary, total | 9 | 5 | 2 |
| skin/soft tissue | |||
| M. abscessus complex | 2 | 0 | 0 |
| M. chelonae | 3 | 1 | 1 |
| bone | |||
| M. abscessus complex | 1 | 0 | 0 |
| multiple | |||
| M. abscessus complex | 0 | 1 | 0 |
| M. chelonae | 1 | 1 | 0 |
| blood | |||
| M. abscessus complex | 1 | 0 | 0 |
| M. abscessus complex/ M. chelonae | 0 | 0 | 1 |
| CNS | |||
| M. abscessus complex | 0 | 1 | 0 |
| prosthesis | |||
| M. abscessus complex | 0 | 1 | 0 |
| prophylaxis | |||
| M. abscessus complex | 1 | 0 | 0 |
aPatients in this table were not separated into treatment groups of <1 or ≥1 month as in Table 3.